W. Watson Buchanan

8.3k total citations · 2 hit papers
219 papers, 6.3k citations indexed

About

W. Watson Buchanan is a scholar working on Rheumatology, Pharmacology and Surgery. According to data from OpenAlex, W. Watson Buchanan has authored 219 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Rheumatology, 34 papers in Pharmacology and 26 papers in Surgery. Recurrent topics in W. Watson Buchanan's work include Rheumatoid Arthritis Research and Therapies (54 papers), Inflammatory mediators and NSAID effects (27 papers) and Systemic Lupus Erythematosus Research (24 papers). W. Watson Buchanan is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (54 papers), Inflammatory mediators and NSAID effects (27 papers) and Systemic Lupus Erythematosus Research (24 papers). W. Watson Buchanan collaborates with scholars based in United Kingdom, Canada and Japan. W. Watson Buchanan's co-authors include M K Jasani, Nicholas Bellamy, James Boyle, Theodore G. Dalakos, Joseph J. Bunim, Kurt J. Bloch, W C Dick, Martin J. Wohl, Walter F. Kean and K Whaley and has published in prestigious journals such as The Lancet, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

W. Watson Buchanan

205 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CLINICAL STUDIES WITH AN ARTICULAR INDEX FOR THE ASSESSMENT OF JOINT TENDERNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS

1968 1.2k citations W. Watson Buchanan et al. QJM profile →
SJÖGRENʼS SYNDROME

1965 622 citations W. Watson Buchanan et al. profile →

Peers

Countries citing papers authored by W. Watson Buchanan

Since Specialization

Citations

This map shows the geographic impact of W. Watson Buchanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Watson Buchanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Watson Buchanan more than expected).

Fields of papers citing papers by W. Watson Buchanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Watson Buchanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Watson Buchanan. The network helps show where W. Watson Buchanan may publish in the future.

Co-authorship network of co-authors of W. Watson Buchanan

This figure shows the co-authorship network connecting the top 25 collaborators of W. Watson Buchanan. A scholar is included among the top collaborators of W. Watson Buchanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Watson Buchanan. W. Watson Buchanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sjögren’s syndrome 2023 ·Inflammopharmacology ·Géza Bálint, W. Watson Buchanan, (unknown), Walter F. Kean, K. D. Rainsford	11
2	Clinical therapeutic trials 2023 ·Inflammopharmacology ·W. Watson Buchanan, (unknown), K. D. Rainsford, Walter F. Kean	2
3	Rheumatoid arthritis 2023 ·Inflammopharmacology ·W. Watson Buchanan, (unknown), Walter F. Kean, K. D. Rainsford	6
4	The effect of the thermal mineral water of Nagybaracska on patients with knee joint osteoarthritis—a double blind study 2006 ·Clinical Rheumatology ·Géza Bálint, W. Watson Buchanan, (unknown), (unknown), (unknown), P Bálint, (unknown), Ildikó Katalin Tefner, Tamás Bender	59
5	History and current status of osteoarthritis in the population 2003 ·Inflammopharmacology ·W. Watson Buchanan, Walter F. Kean, (unknown)	9
6	The treatment of acute rheumatism by salicin, by T.J. Maclagan--The Lancet, 1876. 2002 ·PubMed ·W. Watson Buchanan, Walter F. Kean	11
7	Antirheumatic Drug Therapy in the Elderly: A Case of Failure to Identify the Correct Issues? 1987 ·Journal of the American Geriatrics Society ·Walter F. Kean, W. Watson Buchanan	3
8	Rheumatoid Arthritis: Some Personal Considerations on Aetiology and Treatment Part 1 1983 ·International Journal of Clinical Practice ·Walter F. Kean, W. Watson Buchanan	0
9	Prior gold therapy does not influence the adverse effects of D‐penicillamine in rheumatoid arthritis 1982 ·Arthritis & Rheumatism ·Walter F. Kean, C. J. L. Lock, H. E. Howard-Lock, W. Watson Buchanan	15
10	Recent advances in rheumatology 1976 ·Churchill Livingstone eBooks ·W. Watson Buchanan, W. Carson Dick	10
11	Poor quality of posts in clinical rheumatology: a cause of failure to advance the specialty. 1976 ·BMJ ·W. Watson Buchanan, R D Sturrock, W. Carson Dick	4
12	Indomethacin--aspirin interaction: a clinical appraisal. 1975 ·BMJ ·Peter Brooks, James J. Walker, M. Anne Bell, W. Watson Buchanan, (unknown)	40
13	Observations on Drug Prescribing in Rheumatoid Arthritis 1974 ·BMJ ·(unknown), Sofia Ahola, D M Grennan, Peter Brooks, W. Watson Buchanan	37
14	Sjøgren's Syndrome<subtitle>2. CLINICAL ASSOCIATIONS AND IMMUNOLOGICAL PHENOMENA</subtitle> 1973 ·QJM ·K Whaley, J. Webb, (unknown), G R Hughes, (unknown), R N MacSween, W. Watson Buchanan	103
15	Effect of Anti-inflammatory Drug Therapy on Clearance of 133Xe from Knee Joints of Patients with Rheumatoid Arthritis 1969 ·BMJ ·(unknown), P. Dick, G. Nuki, K Whaley, (unknown), A. Shenkin, Walker Downie, W. Watson Buchanan	10
16	Gastric studies in sjögren's syndrome. 1966 ·Gut ·W. Watson Buchanan, A. G. Cox, Ronald M. Harden, A.I.M. Glen, John R. Anderson, K.G. Gray	30
17	Diagnostic tests for thyroid antibodies: A comparison of the precipitin and latex-fixation (Hyland TA ) tests 1962 ·Journal of Clinical Pathology ·John R. Anderson, W. Watson Buchanan, R. B. Goudie, K.G. Gray	28
18	ASSOCIATION OF HASHIMOTO'S THYROIDITIS AND RHEUMATOID ARTHRITIS 1961 ·The Lancet ·W. Watson Buchanan, J. Crooks, W.D. Alexander, D. A. Koutras, E. J. Wayne, K.G. Gray	71
19	STABLE IODINE METABOLISM IN NON-TOXIC GOITRE 1960 ·The Lancet ·D. A. Koutras, W.D. Alexander, W. Watson Buchanan, J. Crooks, E. J. Wayne	26
20	LONG-TERM PROPHYLACTIC ADMINISTRATION OF TETRACYCLINE TO CHRONIC BRONCHITICS 1958 ·The Lancet ·(unknown), W. Watson Buchanan, A. G. Melrose, John McGuinness, (unknown)	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact